TR199900527T2 - Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi. - Google Patents

Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi.

Info

Publication number
TR199900527T2
TR199900527T2 TR1999/00527T TR9900527T TR199900527T2 TR 199900527 T2 TR199900527 T2 TR 199900527T2 TR 1999/00527 T TR1999/00527 T TR 1999/00527T TR 9900527 T TR9900527 T TR 9900527T TR 199900527 T2 TR199900527 T2 TR 199900527T2
Authority
TR
Turkey
Prior art keywords
treatment
neurological disorders
pain
neuralgia
benzopyranols
Prior art date
Application number
TR1999/00527T
Other languages
English (en)
Inventor
Parsons Andrew
Thompson Mervyn
Upton Neil
Morris Evans John
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR199900527T2 publication Critical patent/TR199900527T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Huntingdon koresi, sizofreni; AIDS, düzensiz uyku (sirkadyan ritim bozukluklari, uykusuzluk ve narkolepsi dahil), tikler (örnegin Giles de la Tourette sendromu), travmatik beyin hasari, tinnitus, nöralji, özellikle trigeminal nöralji, nörofatik aci, dis agrisi, kanser agrisi; diyabetik, çoklu sikleroz (MS) ve motor sinir hastaligi, ataksiyaz, kas sertligi (spastiklik) ve temporomandibular eklem islemezligi gibi nörodisteziyaz ile sonuçlanan uygunsuz nöron faaliyeti ile ilgili nörolojik bozukluklar gibi dejeneratif bozukluklarin tedavisi ve/veya profilaksisi için, faydali benzopiran türevleri ve benzerleri kapsamda yer almaktadir.
TR1999/00527T 1996-09-18 1997-09-15 Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi. TR199900527T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment

Publications (1)

Publication Number Publication Date
TR199900527T2 true TR199900527T2 (tr) 1999-06-21

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00527T TR199900527T2 (tr) 1996-09-18 1997-09-15 Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi.

Country Status (30)

Country Link
EP (1) EP0939630B1 (tr)
JP (1) JP2001500520A (tr)
KR (1) KR20000036184A (tr)
CN (1) CN1230885A (tr)
AP (1) AP9901473A0 (tr)
AR (1) AR008838A1 (tr)
AT (1) ATE270102T1 (tr)
AU (1) AU730465B2 (tr)
BG (1) BG103252A (tr)
BR (1) BR9712030A (tr)
CA (1) CA2266681A1 (tr)
DE (1) DE69729735T2 (tr)
DZ (1) DZ2311A1 (tr)
EA (1) EA199900306A1 (tr)
ES (1) ES2223075T3 (tr)
GB (1) GB9619492D0 (tr)
HU (1) HUP9904638A3 (tr)
ID (2) ID23175A (tr)
IL (1) IL128786A0 (tr)
MA (1) MA24321A1 (tr)
NO (1) NO991292L (tr)
NZ (1) NZ334271A (tr)
OA (1) OA10998A (tr)
PE (1) PE109898A1 (tr)
PL (1) PL332313A1 (tr)
SK (1) SK35199A3 (tr)
TR (1) TR199900527T2 (tr)
UY (1) UY24717A1 (tr)
WO (1) WO1998011890A1 (tr)
ZA (1) ZA978359B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
WO2009147441A2 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
US20130281524A1 (en) * 2008-06-05 2013-10-24 Peter Blower Novel treatments
LT2464645T (lt) 2009-07-27 2017-10-25 Gilead Sciences, Inc. Kondensuoti heterocikliniai junginiai, kaip jonų kanalų moduliatoriai
CA2782631A1 (en) * 2009-12-03 2011-06-09 Proximagen Ltd Treatment of infectious diseases
WO2011067608A1 (en) * 2009-12-03 2011-06-09 Minster Research Ltd Treatment of allodynia and hyperalgesia
BR112012033402A2 (pt) 2010-07-02 2017-01-24 Gilead Sciences Inc moduladores de canais de íons conforme os compostos heterocíclicos fundidos
PT2707361T (pt) 2011-05-10 2017-11-28 Gilead Sciences Inc Compostos heterocíclicos fusionados como moduladores do canal de sódio
NO3175985T3 (tr) 2011-07-01 2018-04-28
TWI622583B (zh) 2011-07-01 2018-05-01 基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
DE69524871T2 (de) * 1994-06-10 2002-08-22 Smithkline Beecham Plc Benzopyrans und deren verwendung als therapeutische mittel

Also Published As

Publication number Publication date
HUP9904638A2 (hu) 2001-05-28
PE109898A1 (es) 1999-03-21
EP0939630B1 (en) 2004-06-30
AP9901473A0 (en) 1999-03-31
MA24321A1 (fr) 1998-04-01
ID23175A (id) 2000-03-23
DE69729735T2 (de) 2005-07-14
IL128786A0 (en) 2000-01-31
ID19542A (id) 1998-07-23
DZ2311A1 (fr) 2002-12-28
ATE270102T1 (de) 2004-07-15
CA2266681A1 (en) 1998-03-26
NZ334271A (en) 2001-03-30
NO991292D0 (no) 1999-03-17
SK35199A3 (en) 2000-07-11
JP2001500520A (ja) 2001-01-16
DE69729735D1 (de) 2004-08-05
AU4704797A (en) 1998-04-14
PL332313A1 (en) 1999-08-30
UY24717A1 (es) 2001-08-27
AU730465B2 (en) 2001-03-08
OA10998A (en) 2003-03-04
AR008838A1 (es) 2000-02-23
NO991292L (no) 1999-03-17
ZA978359B (en) 1999-03-17
EA199900306A1 (ru) 1999-08-26
BR9712030A (pt) 1999-08-24
WO1998011890A1 (en) 1998-03-26
EP0939630A1 (en) 1999-09-08
HUP9904638A3 (en) 2001-08-28
ES2223075T3 (es) 2005-02-16
BG103252A (en) 1999-09-30
CN1230885A (zh) 1999-10-06
GB9619492D0 (en) 1996-10-30
KR20000036184A (ko) 2000-06-26

Similar Documents

Publication Publication Date Title
UA41906C2 (uk) Спосіб лікування неврологічних порушень, викликаних травмами
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
LTIP919A (en) Drugs and process for preparing thereof
DE69213814T2 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
AU2267192A (en) Treatment of migraine by nerve stimulation
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
AU2259292A (en) Treatment of neuropsychiatric disorders by nerve stimulation
AU2339792A (en) Treatment of respiratory disorders by nerve stimulation
ATE192045T1 (de) Verwendung von substituierten adeninderivaten zur behandlung von multiplesklerose
TR199900527T2 (tr) Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi.
AU2399892A (en) Treatment of anxiety disorders by nerve stimulation
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
AU2173400A (en) Method for administering agents to the central nervous system
DE69431199D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
PT656209E (pt) Derivados de melatonina para uso no tratamento de perturbacoes de dessincronizacao
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
EP0745597A3 (en) Novel melatonergic indanyl piperazines or homopiperazines
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
ECSP972256A (es) Nuevo tratamiento y/o profilaxis de enfermedades degenerativas
RU94034011A (ru) Способ лечения психического расстройства
RU94039254A (ru) Способ управления физиологическим состоянием организма в геронтологическом периоде онтогенеза